Helena Käck

7PUBLICATIONS
21CO-AUTHORS
Biomolecular modelling and designBiologically active moleculesCheminformatics and quantitative structure-activity relationshipsProteins and peptidesToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 24, 2025
Protein crystallization strategies in structure-based drug design.

Margareta Ek, Linda Öster, Helena Käck

|Aug 21, 2025
Fragment-Based Drug Discovery of Novel High-affinity, Selective, and Anti-inflammatory Inhibitors of the Keap1-Nrf2 Protein-Protein Interaction.

Chunyu Lin, Dilip Narayanan, Marilia Barreca

|Feb 06, 2025
Macromolecular crystallography from an industrial perspective - the impact of synchrotron radiation on structure-based drug discovery.

H Käck, T Sjögren

|Jul 29, 2024
Exploring serial crystallography for drug discovery.

A Dunge, C Phan, O Uwangue

|Oct 13, 2023
A cell-active cyclic peptide targeting the Nrf2/Keap1 protein-protein interaction.

Jessica Iegre, Sona Krajcovicova, Anders Gunnarsson

|Aug 16, 2019
Discovery of the Oral Leukotriene C4 Synthase Inhibitor (1S,2S)-2-({5-[(5-Chloro-2,4-difluorophenyl)(2-fluoro-2-methylpropyl)amino]-3-methoxypyrazin-2-yl}carbonyl)cyclopropanecarboxylic Acid (AZD9898) as a New Treatment for Asthma.

Magnus Munck Af Rosenschöld, Petra Johannesson, Antonios Nikitidis

Pageof 2

Frequent Collaborators

2 joint publications

Tove Sjögren

1 joint publications

A Dunge

1 joint publications

Stefan Geschwindner

1 joint publications

Jonathan A Ellman